Filing Details
- Accession Number:
- 0001209191-23-032332
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-25 20:21:21
- Reporting Period:
- 2023-05-23
- Accepted Time:
- 2023-05-25 20:21:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1786205 | Arcellx Inc. | ACLX | Biological Products, (No Disgnostic Substances) (2836) | 472855917 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1930862 | Michelle Gilson | C/O Arcellx, Inc. 25 West Watkins Mill Road, Suite A Gaithersburg MD 20878 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-05-23 | 22,428 | $0.00 | 24,189 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-05-24 | 8,554 | $42.47 | 15,635 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-05-24 | 150 | $41.64 | 15,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-05-25 | 6,000 | $42.77 | 9,485 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2023-05-23 | 22,428 | $0.00 | 22,428 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
44,857 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- Includes 1,761 shares of Common Stock acquired under the Issuer's 2022 Employee Stock Purchase Plan on May 12, 2023.
- Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
- Represents the weighted average share price of an aggregate total of 6,000 shares sold in the price range of $42.73 to $42.8605 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, the RSUs shall vest annually over three (3) years with a cliff every twelve (12) months on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 23, 2022.